176 related articles for article (PubMed ID: 38192634)
1. Iron-Based Nanovehicle Delivering Fin56 for Hyperthermia-Boosted Ferroptosis Therapy Against Osteosarcoma.
Zhang Y; Song Q; Zhang Y; Xiao J; Deng X; Xing X; Hu H; Zhang Y
Int J Nanomedicine; 2024; 19():91-107. PubMed ID: 38192634
[TBL] [Abstract][Full Text] [Related]
2. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
3. High-performance pyrite nano-catalyst driven photothermal/chemodynamic synergistic therapy for Osteosarcoma.
Li M; Wang M; Huang J; Tang S; Yang J; Xu Z; Xu G; Chen X; Liu J; Yang C
J Nanobiotechnology; 2024 Apr; 22(1):141. PubMed ID: 38561739
[TBL] [Abstract][Full Text] [Related]
4. Multivalent Polypeptide and Tannic Acid Cooperatively Iron-Coordinated Nanohybrids for Synergistic Cancer Photothermal Ferroptosis Therapy.
He M; Du C; Xia J; Zhang ZG; Dong CM
Biomacromolecules; 2022 Jun; 23(6):2655-2666. PubMed ID: 35583462
[TBL] [Abstract][Full Text] [Related]
5. Cascade-Enhanced Catalytic Nanocomposite with Glutathione Depletion and Respiration Inhibition for Effective Starving-Chemodynamic Therapy Against Hypoxic Tumor.
Zhang Y; Hu H; Deng X; Song Q; Xing X; Liu W; Zhang Y
Int J Nanomedicine; 2022; 17():5491-5510. PubMed ID: 36438608
[TBL] [Abstract][Full Text] [Related]
6. Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma.
Zhao LX; Gong ZQ; Zhang Q; He DL; Ge RL; Meng J; Ren H; Fan YG; Wang ZY
J Control Release; 2023 Jul; 359():12-25. PubMed ID: 37244298
[TBL] [Abstract][Full Text] [Related]
7. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
8. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells.
Sun Y; Berleth N; Wu W; Schlütermann D; Deitersen J; Stuhldreier F; Berning L; Friedrich A; Akgün S; Mendiburo MJ; Wesselborg S; Conrad M; Berndt C; Stork B
Cell Death Dis; 2021 Oct; 12(11):1028. PubMed ID: 34716292
[TBL] [Abstract][Full Text] [Related]
9. Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy.
Yu H; Yan J; Li Z; Song T; Ning F; Tan J; Sun Y
J Mater Chem B; 2023 Jan; 11(2):415-429. PubMed ID: 36512437
[TBL] [Abstract][Full Text] [Related]
10. A pH-sensitive imidazole grafted polymeric micelles nanoplatform based on ROS amplification for ferroptosis-enhanced chemodynamic therapy.
Zhang Z; Wang L; Guo Z; Sun Y; Yan J
Colloids Surf B Biointerfaces; 2024 May; 237():113871. PubMed ID: 38547796
[TBL] [Abstract][Full Text] [Related]
11. pH-Responsive Sorafenib/Iron-Co-Loaded Mesoporous Polydopamine Nanoparticles for Synergistic Ferroptosis and Photothermal Therapy.
Liu S; Liu Y; Chang Q; Celia C; Deng X; Xie Y
Biomacromolecules; 2024 Jan; 25(1):522-531. PubMed ID: 38087829
[TBL] [Abstract][Full Text] [Related]
12. An active-passive strategy for enhanced synergistic photothermal-ferroptosis therapy in the NIR-I/II biowindows.
Wu F; Chen H; Liu R; Suo Y; Li Q; Zhang Y; Liu H; Cheng Z; Chang Y
Biomater Sci; 2022 Feb; 10(4):1104-1112. PubMed ID: 35044388
[TBL] [Abstract][Full Text] [Related]
13. Theaflavin-3,3'-Digallate Plays a ROS-Mediated Dual Role in Ferroptosis and Apoptosis via the MAPK Pathway in Human Osteosarcoma Cell Lines and Xenografts.
He T; Lin X; Yang C; Chen Z; Wang L; Li Q; Ma J; Zhan F; Wang Y; Yan J; Quan Z
Oxid Med Cell Longev; 2022; 2022():8966368. PubMed ID: 36329803
[TBL] [Abstract][Full Text] [Related]
14. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
[TBL] [Abstract][Full Text] [Related]
15. Iron-based and BRD
Geng L; Lu T; Jing H; Zhou Y; Liang X; Li J; Li N
Acta Pharm Sin B; 2023 Feb; 13(2):863-878. PubMed ID: 36873167
[TBL] [Abstract][Full Text] [Related]
16. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
17. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis.
Wen RJ; Dong X; Zhuang HW; Pang FX; Ding SC; Li N; Mai YX; Zhou ST; Wang JY; Zhang JF
Phytomedicine; 2023 Jul; 116():154881. PubMed ID: 37209607
[TBL] [Abstract][Full Text] [Related]
18. Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer.
Chen Z; Li Z; Li C; Huang H; Ren Y; Li Z; Hu Y; Guo W
Drug Deliv; 2022 Dec; 29(1):1201-1211. PubMed ID: 35403518
[TBL] [Abstract][Full Text] [Related]
19. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
20. Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy.
Xing L; Liu XY; Zhou TJ; Wan X; Wang Y; Jiang HL
J Control Release; 2021 Nov; 339():14-26. PubMed ID: 34547257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
